glp-1 colorectal cancer mortality study november 2025 death risk Patients with obesity who were treated with Emerging Evidence Positions GLP-1 Receptor

It's also important to note that these medications carry a boxed warning for risk of thyroid C-cell tumors and are contraindicated in patients with personal or family history of medullary thyroid carcinoma or Multiple Endocrine Neoplasia syndrome type 2 (MEN2)

Medical Adjustments & Physician Input Sometimes, breaking a weight loss plateau means adjusting your medication dose, timing, or adding supportive therapies

Eli Lillys Misleading Marketing Strategy Promoting Trulicity Since Trulicitys launch in 2014, there have been a number of concerns about Eli Lillys marketing strategy

It damages the small intestine

Call us or book a consultation online to start your journey toward a healthier, stronger you